Clinical Trial Update: Study of Levalbuterol, Racemic Albuterol and Placebo in Subjects Twelve Years of Age and Older With Asthma [Phase 3]

View source ↗

Summary

This document provides an update on a Phase 3 trial comparing levalbuterol, racemic albuterol, and placebo in individuals aged 12 years and older with asthma, n…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• Albuterol (racemic) (albuterol)
• Xopenex (Levalbuterol)

Snippet

Sponsor: Sumitomo Pharma America, Inc. | Conditions: Asthma | Phase 3 | Status: COMPLETED